
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
In a high-stakes maneuver that could reshape the oncology landscape, AstraZeneca Plc AZN is reportedly in talks with Summit Therapeutics Inc. SMMT about a partnership worth up to $15 billion. What Does This Mean? The deal would give AstraZeneca the rights …